Glancy Prongay Wolke & Rotter LLP is alerting investors of Apollo Global Management, Inc. (APO) about an upcoming May 1, 2026, deadline to file as lead plaintiff in a securities fraud class action lawsuit. The lawsuit alleges that Apollo Global made materially false and misleading statements to investors regarding ties between its leadership, including CEO Marc Rowan and former CEO Leon Black, and Jeffrey Epstein. The firm claims Apollo's stock price dropped significantly after news reports detailed these connections, contradicting the company's previous assertions.

Corning's Senior Vice President & CHRO, Michelle L. Gullo, exercised equity awards, converting performance share units and restricted stock units into 13,149 shares. Although 6,198 shares were withheld for tax obligations, her direct ownership of common stock increased to 42,951 shares. Gullo also retains unvested performance and restricted stock units scheduled to vest between April 2026 and April 2029.

Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against PayPal Holdings, Inc. and its officers for alleged violations of federal securities laws. The lawsuit claims that PayPal made false and misleading statements regarding its revenue outlook and growth strategy between February 25, 2025, and February 2, 2026. Investors who suffered losses are encouraged to join the case, with a lead plaintiff deadline of April 20, 2026.

Walmart plans to remodel 58 stores across Florida in 2026, including a Tampa location at 2701 E. Fletcher Ave., to enhance both in-store and online shopping experiences. The upgrades will focus on store layouts, technology, and service offerings to support faster delivery and expanded digital tools. This investment builds on $1.5 billion Walmart has put into Florida over the past five years, reflecting shifts in consumer demand for convenience and digital integration.

HIVE Digital Technologies (NASDAQ:HIVE) shares gapped down significantly, opening at $2.29 after recently closing at $2.47, and last trading at $2.1650, representing a 13.2% drop on high volume. This decline follows several brokerages trimming their price targets for HIVE, though the consensus remains a "Moderate Buy." Institutional investors hold approximately 24% of the company, which specializes in mining digital assets like Bitcoin and Ethereum.

U.S. steel producers Nucor Corp. and Steel Dynamics are anticipating a significant surge in their first-quarter earnings, attributed to increased sales volumes and higher prices. This boost is largely a result of Section 232 tariffs on metal imports, which have redirected demand towards domestic steel and enabled prices to surpass raw material costs. Analyst Seth Goldstein notes that these conditions are expected to persist through most of 2026, depending on the duration of tariffs and geopolitical stability.

IDACORP, Inc. (NYSE:IDA) announced it will report its first quarter 2026 results on Thursday, April 30, before market open. The company will host an analyst conference call at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) on the same day to discuss the earnings. Interested parties can listen via a live webcast or by phone, with a replay available on the company's website.

DA Davidson reissued a "Buy" rating on Tractor Supply (NASDAQ:TSCO) with a $60 price objective, suggesting a 34% upside. While analysts are mixed, the average rating is "Moderate Buy" with a $58.09 price target. The company recently missed quarterly earnings and revenue estimates, and notable insider selling has been observed despite high institutional ownership.

L3Harris Technologies is investing $1.3 billion to expand its solid rocket motor manufacturing capacity in Orange County, Virginia, building on a previous $41.2 million investment. This expansion will establish an advanced propulsion campus, creating over 350 jobs and supporting multiple Department of Defense programs. The move aligns with the DOD's increased demand for weapons systems and the company's new missile solutions business, which seeks an IPO in the second half of 2026.

ICON plc is a crucial contract research organization (CRO) providing end-to-end clinical trial services, positioning it as a strategic investment for those tracking healthcare growth, particularly in the U.S. market. The company benefits from surging biopharma R&D spending and an outsourcing trend among major pharmaceutical firms, offering a full-service model that includes decentralized trials and advanced analytics. ICON's strong market position, technology-driven solutions, and focus on high-need therapeutic areas make it a resilient stock amidst changing economic and regulatory landscapes.